These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9291170)

  • 21. Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis.
    Dudesek A; Zettl UK
    J Neurol; 2006 Sep; 253 Suppl 5():V50-8. PubMed ID: 16998754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long term safety of IVIg therapy in multiple sclerosis: 10 years experience.
    Katz U; Kishner I; Magalashvili D; Shoenfeld Y; Achiron A
    Autoimmunity; 2006 Sep; 39(6):513-7. PubMed ID: 17060031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.
    Hahn AF; Bolton CF; Zochodne D; Feasby TE
    Brain; 1996 Aug; 119 ( Pt 4)():1067-77. PubMed ID: 8813271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Austrian Immunoglobulin in MS (AIMS) study: final analysis.
    Strasser-Fuchs S; Fazekas F; Deisenhammer F; Nahler G; Mamoli B
    Mult Scler; 2000 Oct; 6 Suppl 2():S9-13. PubMed ID: 11188778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis.
    Achiron A; Kishner I; Dolev M; Stern Y; Dulitzky M; Schiff E; Achiron R
    J Neurol; 2004 Sep; 251(9):1133-7. PubMed ID: 15372259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immunoglobulin G therapy: effects of acute and chronic treatment in multiple sclerosis.
    Sørensen PS
    Mult Scler; 1996 Jul; 1(6):349-52. PubMed ID: 9345416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous Immunoglobulins in MS.
    Stangel M; Gold R
    Int MS J; 2005 Apr; 12(1):5-10, 4. PubMed ID: 15955273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, double-blind, placebo-controlled trial: intravenous immunoglobulin treatment in patients with diffuse cutaneous systemic sclerosis.
    Takehara K; Ihn H; Sato S
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):151-6. PubMed ID: 23910617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination with i.v. methylprednisolone in the treatment of relapses in patients with MS.
    Visser LH; Beekman R; Tijssen CC; Uitdehaag BM; Lee ML; Movig KL; Lenderink AW
    Mult Scler; 2004 Feb; 10(1):89-91. PubMed ID: 14760960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study.
    Léger JM; Chassande B; Musset L; Meininger V; Bouche P; Baumann N
    Brain; 2001 Jan; 124(Pt 1):145-53. PubMed ID: 11133794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous immunoglobulin G for the treatment of relapsing-remitting multiple sclerosis: a meta-analysis.
    Sorensen PS; Fazekas F; Lee M
    Eur J Neurol; 2002 Nov; 9(6):557-63. PubMed ID: 12453069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An 'n-of-1' placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris.
    Arnold DF; Burton J; Shine B; Wojnarowska F; Misbah SA
    Br J Dermatol; 2009 May; 160(5):1098-102. PubMed ID: 19222460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of chronic progressive multiple sclerosis with intravenous immunoglobulins--interim results on drug safety of an ongoing study. IVIG study group.
    Poehlau D
    Mult Scler; 2000 Oct; 6 Suppl 2():S21-3. PubMed ID: 11188774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous immunoglobulins in multiple sclerosis.
    Lisak RP
    Neurology; 1998 Dec; 51(6 Suppl 5):S25-9. PubMed ID: 9851727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous immunoglobulin in MS: promise or failure?
    Fazekas F; Strasser-Fuchs S; Hommes OR
    J Neurol Sci; 2007 Aug; 259(1-2):61-6. PubMed ID: 17449063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous immunoglobulin for hypogammaglobulinemia after lung transplantation: a randomized crossover trial.
    Lederer DJ; Philip N; Rybak D; Arcasoy SM; Kawut SM
    PLoS One; 2014; 9(8):e103908. PubMed ID: 25090414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.
    Noseworthy JH; O'Brien PC; van Engelen BG; Rodriguez M
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):11-4. PubMed ID: 7964842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined immunoglobulin and azathioprine in multiple sclerosis.
    Kalanie H; Tabatabai SS
    Eur Neurol; 1998; 39(3):178-81. PubMed ID: 9605396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled study.
    Jablonowska B; Selbing A; Palfi M; Ernerudh J; Kjellberg S; Lindton B
    Hum Reprod; 1999 Mar; 14(3):838-41. PubMed ID: 10221723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect on MRI of gammaglobulin treatment in relapsing multiple sclerosis.
    Sørensen PS
    Mult Scler; 2000 Oct; 6 Suppl 2():S14-7. PubMed ID: 11188772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.